Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000905718-19-000210
Filing Date
2019-02-14
Accepted
2019-02-14 16:09:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 recropharma_13gdec312018.htm SC 13G 40046
  Complete submission text file 0000905718-19-000210.txt   41498
Mailing Address 405 PARK AVENUE SUITE 1104 NEW YORK NY 10022-9409
Business Address 405 PARK AVENUE SUITE 1104 NEW YORK NY 10022-9409 212-446-2460
Newtyn Management, LLC (Filed by) CIK: 0001569241 (see all company filings)

EIN.: 453017573 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Subject) CIK: 0001588972 (see all company filings)

EIN.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88042 | Film No.: 19606245
SIC: 2834 Pharmaceutical Preparations